BMC public health · 2026
The Covid-19 pandemic as an inflection point in US mortality trends from hematologic and circulatory system diseases: a piecewise trend analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bachemir Amirali Koohi, Sun Zhenshan, Safari Melika, Borumandnia Nasrin, Majd Hamid Alavi
Аннотация
BACKGROUND: The COVID-19 pandemic disrupted healthcare systems and may have influenced mortality trends in hematologic-immune disorders (D50-D89) and Diseases of the circulatory system (I00-I99). This study evaluates US mortality trends from 2010 to 2023 to assess potential pandemic-related changes.
METHODS: We utilized spline regression modeling on CDC WONDER mortality data (2010-2023) to quantify post-pandemic trend shifts in both age-adjusted and sex/age-stratified mortality rates.
RESULT: Post-2019 mortality trends for D50-D89 and I00-I99 diseases showed significant increases, particularly among older adults and younger males. D50-D89 mortality in females ≥ 65 increased ~ 2.6% (95% CI 1.70% to 3.68%) annually, while males ≥ 65 increased ~ 1.6% (95% CI 0.28% to 3.07%) annually; younger males (15-34 years) showed a 4.5% (95% CI 0.49% to 8.87%) annual increase. I00-I99 mortality increases were most pronounced in older females (~ 1.4% annual increase, 95% CI 0.49 to 2.31). Analysis of standardized rates in all groups except for men in I00-I99 showed a positive slope-shift after 2019. (p < 0.05)".
CONCLUSION: These findings highlight the persistent impact of the COVID-19 pandemic on hematologic and circulatory system disease mortality, emphasizing the need for continued monitoring of vulnerable populations.
METHODS: We utilized spline regression modeling on CDC WONDER mortality data (2010-2023) to quantify post-pandemic trend shifts in both age-adjusted and sex/age-stratified mortality rates.
RESULT: Post-2019 mortality trends for D50-D89 and I00-I99 diseases showed significant increases, particularly among older adults and younger males. D50-D89 mortality in females ≥ 65 increased ~ 2.6% (95% CI 1.70% to 3.68%) annually, while males ≥ 65 increased ~ 1.6% (95% CI 0.28% to 3.07%) annually; younger males (15-34 years) showed a 4.5% (95% CI 0.49% to 8.87%) annual increase. I00-I99 mortality increases were most pronounced in older females (~ 1.4% annual increase, 95% CI 0.49 to 2.31). Analysis of standardized rates in all groups except for men in I00-I99 showed a positive slope-shift after 2019. (p < 0.05)".
CONCLUSION: These findings highlight the persistent impact of the COVID-19 pandemic on hematologic and circulatory system disease mortality, emphasizing the need for continued monitoring of vulnerable populations.